Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 487 of 1,261

  1. US 10350267

    Polypeptide-polymer conjugates and methods of use thereof

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  2. US 10350239

    Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

    Propanc Pty Ltd · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  3. US 10344078

    Type III secretion system targeting molecules

    Inhibrx, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  4. US 10345310

    Diagnostic test for early stage cancer

    The Board of Regents of the University of Texas System · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  5. US 10344271

    Modified zinc finger binding proteins

    Sangamo Therapeutics, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  6. US 10344064

    Engineered potent cytotoxic stapled BH3 peptides

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  7. US 10344061

    Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  8. US 10344033

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  9. US 10344025

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  10. US 10343981

    Modulators of the eIF2alpha pathway

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  11. US 10343903

    Cationic polymer coated mesoporous silica nanoparticles and uses thereof

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  12. US 10344027

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  13. US 10342882

    TCO conjugates and methods for delivery of therapeutic agents

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  14. US 10342871

    Compositions containing nucleosides and manganese and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  15. US 10342867

    Adjuvants

    LITEVAX B.V. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  16. US 10342869

    Compositions comprising anti-CD38 antibodies and lenalidomide

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  17. US 10342822

    Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

    The Board of Regents of the University of Texas System · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  18. US 10342804

    Steroid compound for use in the treatment of hepatic encephalopathy

    Umecrine Cognition AB · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  19. US 10342776

    Compositions and methods for controlling infections

    Regents of the University of Minnesota · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  20. US 10342791

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    The United States of America as represented by the Secretary of the Army · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  21. US 10342764

    Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

    Oramed Ltd. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  22. US 10344040

    Pyridone and aza-pyridone compounds and methods of use

    GILEAD CONNECTICUT, INC. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  23. US 10342876

    Process for reducing subvisible particles in a pharmaceutical formulation

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  24. US 10344096

    Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.